The structural changes that occur in the airways of patients who have obstructive lung disease are the result of the host response to tissue injury. This complex process is influenced by both the genetic makeup of the host and the environmental insults which incite the injury. There is marked inter-individual variation in the response to these insults and those who have an exaggerated repair reaction develop more airway obstruction due to fibrosis and scaring. The investigators will take advantage of a large clinical and tissue registry of more than 1400 patients which has been collected over the past 20 years. In addition recent technical advances in the precision of High Resolution Computed Tomography (HRCT) will be used to quantify airway dimensions in life in patients who have Asthma and COPD. The differences in the composition of the connective tissue, and smooth muscle proteins which accumulate in the airway walls of patients with these disorders will be measured using immunohistochemistry, western analysis and measurement of mRNA. The hypotheses that will be tested include: 1) that the airway wall thickening in obstructive airway disease can be measured accurately using HRCT, 2) that abnormal scaring of the airway is related to alterations in the ratios of Platelet Derived Growth Factor (PDGF) and Transforming Growth Factor beta (TGFbeta), and of the relative abundance of the three TGFbeta isoforms TGFbeta1, TGFbeta2, TGFbeta3, 3) that increased airway smooth muscle force generation in airway disease is due to increased expression of contractile proteins by the muscle and increased formation of a compliant extracellular matrix, and 4) that specific gene polymorphisms in key matrix proteins is at the basis of individual susceptibility.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL064068-03
Application #
6390587
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (S1))
Program Officer
Noel, Patricia
Project Start
1999-09-30
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$200,000
Indirect Cost
Name
University of British Columbia
Department
Type
DUNS #
800772162
City
Vancouver
State
BC
Country
Canada
Zip Code
V6 1-Z3
Wang, Yu; Shumansky, Karey; Sin, Don D et al. (2015) Associations of interleukin-1 gene cluster polymorphisms with C-reactive protein concentration and lung function decline in smoking-induced chronic obstructive pulmonary disease. Int J Clin Exp Pathol 8:13125-35
Aminuddin, Farzian; Hackett, Tillie-Louise; Stefanowicz, Dorota et al. (2013) Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. BMC Pulm Med 13:64
Aminuddin, F; Akhabir, L; Stefanowicz, D et al. (2012) Genetic association between human chitinases and lung function in COPD. Hum Genet 131:1105-14
Sandford, Andrew J; Malhotra, Deepti; Boezen, H Marike et al. (2012) NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease. Physiol Genomics 44:754-63
Tanaka, Goh; Aminuddin, Farzian; Akhabir, Loubna et al. (2011) Effect of heme oxygenase-1 polymorphisms on lung function and gene expression. BMC Med Genet 12:117
He, J-Q; Foreman, M G; Shumansky, K et al. (2009) Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64:698-704
He, J-Q; Shumansky, K; Connett, J E et al. (2008) Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD. Eur Respir J 32:25-34
Tanaka, G; Sandford, A J; Burkett, K et al. (2007) Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 29:34-41
Ogawa, Emiko; Ruan, Jian; Connett, John E et al. (2007) Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers. Respir Med 101:938-43
He, J-Q; Shumansky, K; Zhang, X et al. (2007) Polymorphisms of interleukin-10 and its receptor and lung function in COPD. Eur Respir J 29:1120-6

Showing the most recent 10 out of 21 publications